Show simple item record

dc.contributor.authorSirin, A
dc.contributor.authorBilge, I
dc.contributor.authorEmre, S
dc.contributor.authorAydin, K
dc.contributor.authorTatli, B
dc.contributor.authorSadikoglu, B
dc.date.accessioned2021-03-05T18:34:03Z
dc.date.available2021-03-05T18:34:03Z
dc.date.issued2005
dc.identifier.citationBilge I., Sadikoglu B., Emre S., Sirin A., Aydin K., Tatli B., "Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient", PEDIATRIC NEPHROLOGY, cilt.20, ss.529-533, 2005
dc.identifier.issn0931-041X
dc.identifier.otherav_caf6e88f-8b01-4cf3-95ce-bbb3811eb501
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/134466
dc.identifier.urihttps://doi.org/10.1007/s00467-004-1736-1
dc.description.abstractCentral nervous system (CNS)vasculitis secondary to chronic parvovirus B19 (B19) infection presenting with recurrent neurological findings is a very rare disorder during childhood. Here we report a 12-year-old boy with a renal transplant who had chronic B19 infection with skin eruptions and recurrent episodes of encephalopathy with focal neurological deficits. B19 DNA was detected in blood, bone marrow, and skin biopsy specimens. Repeat cranial magnetic resonance (MR) imaging during each episode of encephalopathy showed variable focal findings, and MR angiography revealed vasculitic changes with narrowing of the cerebral arteries. We hypothesized that the CNS vasculitis might be associated with the chronic B19 infection. At the time of his fourth presentation with the same clinical findings, we administered intravenous immunoglobulin (IVIG) (1 g/kg per day, 2 consecutive days), which we continued for 6 months, at monthly intervals. IVIG therapy resulted in remission and has been effective not only for the clearance of B19, but also for the improvement of clinical and radiological findings of CNS vasculitis. We suggest that chronic B19 infection should be considered in immunocompromised patients with suspected CNS vasculitis. IVIG should be considered as a part of the treatment.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectNefroloji
dc.subjectSağlık Bilimleri
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectPEDİATRİ
dc.titleCentral nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient
dc.typeMakale
dc.relation.journalPEDIATRIC NEPHROLOGY
dc.contributor.department, ,
dc.identifier.volume20
dc.identifier.issue4
dc.identifier.startpage529
dc.identifier.endpage533
dc.contributor.firstauthorID174802


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record